Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×

ClearOne wins patent trial against Shure

Shure will appeal

ClearOne today announced that a jury in the U.S. District Court for the District of Delaware has found that ClearOne’s innovative Ceiling Tile Beamforming Mic Array line of products do not infringe Shure Incorporated’s U.S. Patent No. D865,723 (the “’723 patent”). The jury also found that the ’723 patent is invalid.

“We are very pleased that the jury found that ClearOne’s BMA CT products did not infringe and invalidated Shure’s patent.” Zee Hakimoglu, president and chief executive officer of ClearOne Shure was using the ‘723 patent to retaliate against ClearOne, and the jury’s verdict validates ClearOne’s refusal to give in to Shure’s tactics.”

Shure responded with the following statement: “Shure is disappointed by the jury’s findings that our ‘723 patent is not valid and was not infringed.  We believe the United States Patent Office correctly recognized Shure’s novel design when it issued the ‘723 patent, and ClearOne‘s BMA CT products infringe that design.  We intend to appeal both rulings.” 

The products that Shure accused of infringement in this case were the BMA CT, BMA CTH (i.e. the COLLABORATE Versa Pro CTCOLLABORATE Versa Lite CTCOLLABORATE Versa Room CT), BMA 360, and BMA-CTX (“Xceed”).

ClearOne and Shure are also involved in litigation in the U.S. District Court for the Northern District of Illinois. In August 2019, Judge Edmond E. Chang of that Court granted ClearOne’s request for a preliminary injunction (“PI Order”) preventing Shure from “manufacturing, marketing, and selling” the original MXA910 for use “in its drop-ceiling mounting configuration.”

Shure responds to preliminary injunction

 

 

Featured Articles

Close